含益生元精氨酸与益生菌含片对儿童龋齿增量影响的随机临床试验
这项安慰剂对照双盲随机试验纳入343名5-9岁儿童,每日使用含精氨酸和两种益生菌的含片10-12个月。完成后288名儿童,干预组龋齿增量(dICDAS3-6msf-s等)显著低于对照组(p=0.007),但牙龈炎和菌斑无差异,无产品相关副作用。
要点
- 每日含服精氨酸与益生菌含片可显著降低儿童龋齿增量。
- 该含片对牙龈炎和菌斑发生率无显著影响。
- 产品使用安全,未报告相关副作用。
核心结论
- 每日使用含益生元精氨酸和两种益生菌的含片安全,且能统计学显著降低儿童龋齿增量,但对菌斑和牙龈炎无影响。
研究设计与样本
- 安慰剂对照、双盲、平行组随机临床试验,343名5-9岁儿童随机1:1分配,干预组172名,安慰剂组171名,随访10-12个月。
主要发现
- 完成研究288名儿童,脱落率15%。
- 干预组∆mean dICDAS3-6msf-s和∆mean d/DICDAS3-6m/M-s/S-f/F-s/S增量低于对照组(p=0.007)。
- 牙龈炎和菌斑发生率两组无差异。
- 未报告产品相关副作用。
关键数值与推荐
- 龋齿检查采用临床ICDAS1-6和影像学R1-6评分,包括缺失、封闭、充填面。
- 使用加权和非加权评分系统评估龋齿经验。
临床怎么用
- 含精氨酸和益生菌的含片可作为氟化物牙膏刷牙的辅助手段,用于管理儿童龋齿增量。
局限性
- 脱落率15%,可能影响结果解释。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate the effect of daily use of a lozenge containing arginine and probiotics for 10-12 months on caries increment, gingivitis- and plaque occurrence in children aged 5-9 years. METHODS: In this placebo-controlled, double-blinded, parallel-grouped randomized clinical trial, 343 children were randomly assigned to one of the study arms (1:1). The intervention group (n = 172) received a lozenge containing Lacticaseibacillus rhamnosus, LGG® (DSM33156), Lactobacillus paracasei subsp. paracasei, L. CASEI 431® (DSM33451) and prebiotic (arginine 2%). The placebo group (n = 171) received an identical lozenge without arginine or probiotics. Primary canines and molars, and permanent first molars were examined clinically (d/D= ICDAS1-6) and radiographically (d/D = R1-6) at baseline and follow-up. Missing (m/M), sealed (s/S), and filled (f/F) surfaces (-s/-S) in both dentitions were also included. Utilizing clinical and radiographic scorings, caries experience was classified as dICDAS1-6msf-s (primary teeth), DICDAS1-6MSF-S (permanent teeth), d/DICDAS1-6 m/M-s/S-f/F-s/S (mixed dentition). A weighted and an unweighted score system was applied. RESULTS: The study was completed by 288 children. The dropout rate was 15%. The increase in ∆mean dICDAS3-6msf-s and ∆mean d/DICDAS3-6m/M-s/S-f/F-s/S was lower in the intervention group (p = 0.007). No differences were found for gingivitis- and plaque occurrence. No product-related side effects were reported. This study followed ICH-GCP including external monitoring. CONCLUSION: Daily consumption of a lozenge containing prebiotic arginine and two strains of probiotics showed safe use and statistically significantly reduction in caries incrementbut no effect on the mean plaque or gingivitis occurrence in children. The use of a lozenge with arginine and probiotics combined has a promising potential as a supplementary tool for future management of caries. www. CLINICALTRIALS: gov (NCT03928587). CLINICAL SIGNIFICANCE: The combination of prebiotic arginine and probiotics shows clinical potential as a supplementary approach to toothbrushing with fluoride toothpaste in managing caries increment in children. A new era in the management of caries may be emerging.
引用
- Pørksen CJ, Keller MK, Damholt A, et al. The effect of a lozenge combining prebiotic arginine and probiotics on caries increment in children during 10-12 months, a randomized clinical trial. J Dent. 2023. PMID: 37356561. doi:10.1016/j.jdent.2023.104599
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。